annual accounts payable:
$5.07M-$3.53M(-41.03%)Summary
- As of today (July 1, 2025), XENE annual accounts payable is $5.07 million, with the most recent change of -$3.53 million (-41.03%) on December 31, 2024.
- During the last 3 years, XENE annual accounts payable has risen by +$1.25 million (+32.58%).
- XENE annual accounts payable is now -41.03% below its all-time high of $8.60 million, reached on December 31, 2023.
Performance
XENE Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly accounts payable:
$6.88M+$1.81M(+35.74%)Summary
- As of today (July 1, 2025), XENE quarterly accounts payable is $6.88 million, with the most recent change of +$1.81 million (+35.74%) on March 31, 2025.
- Over the past year, XENE quarterly accounts payable has increased by +$452.00 thousand (+7.03%).
- XENE quarterly accounts payable is now -42.77% below its all-time high of $12.03 million, reached on June 30, 2023.
Performance
XENE quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
XENE Accounts payable Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -41.0% | +7.0% |
3 y3 years | +32.6% | +314.8% |
5 y5 years | +105.0% | +113.9% |
XENE Accounts payable Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -41.0% | +32.6% | -42.8% | +123.3% |
5 y | 5-year | -41.0% | +105.0% | -42.8% | +321.4% |
alltime | all time | -41.0% | +1196.7% | -42.8% | +1660.1% |
XENE Accounts payable History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $6.88M(+35.7%) |
Dec 2024 | $5.07M(-41.0%) | $5.07M(-6.5%) |
Sep 2024 | - | $5.42M(-42.9%) |
Jun 2024 | - | $9.50M(+47.7%) |
Mar 2024 | - | $6.43M(-25.2%) |
Dec 2023 | $8.60M(+1.3%) | $8.60M(+41.0%) |
Sep 2023 | - | $6.10M(-49.3%) |
Jun 2023 | - | $12.03M(+5.4%) |
Mar 2023 | - | $11.41M(+34.4%) |
Dec 2022 | $8.49M(+122.0%) | $8.49M(+175.5%) |
Sep 2022 | - | $3.08M(-3.0%) |
Jun 2022 | - | $3.18M(+91.6%) |
Mar 2022 | - | $1.66M(-56.6%) |
Dec 2021 | $3.82M(+25.7%) | $3.82M(+24.0%) |
Sep 2021 | - | $3.08M(-5.9%) |
Jun 2021 | - | $3.28M(+53.8%) |
Mar 2021 | - | $2.13M(-29.9%) |
Dec 2020 | $3.04M(+23.0%) | $3.04M(+38.4%) |
Sep 2020 | - | $2.20M(+34.6%) |
Jun 2020 | - | $1.63M(-49.2%) |
Mar 2020 | - | $3.22M(+30.1%) |
Dec 2019 | $2.47M | $2.47M(+80.4%) |
Sep 2019 | - | $1.37M(-8.5%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2019 | - | $1.50M(+39.9%) |
Mar 2019 | - | $1.07M(+61.1%) |
Dec 2018 | $665.00K(-46.9%) | $665.00K(-30.7%) |
Sep 2018 | - | $959.00K(+12.4%) |
Jun 2018 | - | $853.00K(+80.3%) |
Mar 2018 | - | $473.00K(-62.3%) |
Dec 2017 | $1.25M(-14.4%) | $1.25M(+54.9%) |
Sep 2017 | - | $809.00K(-38.4%) |
Jun 2017 | - | $1.31M(+12.8%) |
Mar 2017 | - | $1.17M(-20.4%) |
Dec 2016 | $1.46M(+34.5%) | $1.46M(+185.7%) |
Sep 2016 | - | $512.00K(-21.8%) |
Jun 2016 | - | $655.00K(-36.0%) |
Mar 2016 | - | $1.02M(-6.0%) |
Dec 2015 | $1.09M(+96.7%) | $1.09M(+33.2%) |
Sep 2015 | - | $817.00K(-6.3%) |
Jun 2015 | - | $872.00K(+38.0%) |
Mar 2015 | - | $632.00K(+14.3%) |
Dec 2014 | $553.00K(+41.4%) | $553.00K(+8.2%) |
Sep 2014 | - | $511.00K(-17.6%) |
Jun 2014 | - | $620.00K(+58.6%) |
Dec 2013 | $391.00K(-52.4%) | $391.00K |
Dec 2012 | $821.00K | - |
FAQ
- What is Xenon Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals annual accounts payable year-on-year change?
- What is Xenon Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals quarterly accounts payable year-on-year change?
What is Xenon Pharmaceuticals annual accounts payable?
The current annual accounts payable of XENE is $5.07M
What is the all time high annual accounts payable for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high annual accounts payable is $8.60M
What is Xenon Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, XENE annual accounts payable has changed by -$3.53M (-41.03%)
What is Xenon Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of XENE is $6.88M
What is the all time high quarterly accounts payable for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high quarterly accounts payable is $12.03M
What is Xenon Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, XENE quarterly accounts payable has changed by +$452.00K (+7.03%)